Increased NSE levels are associated with oxidative damage as a diagnostic marker in numerous neurodegenerative diseases such as Huntington's disease, Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis22–25. This evidence concerns the gene ENO2 and early-onset autosomal dominant Alzheimer disease.